Lastly, elevated CD73 expression in the tumor tissue has been reported to be associated with advanced clinical stage and poor prognosis in several cancer types (23, 45, 46), which underscores the crucial role of CD73 in tumor progression. This evidence concerns the gene NT5E and neoplasm.